Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Woodham AW, Cheloha RW, Ling J, Rashidian M, Kolifrath SC, Mesyngier M, Duarte JN, Bader JM, Skeate JG, Da Silva DM, Kast WM, Ploegh HL.

Cancer Immunol Res. 2018 May 23. doi: 10.1158/2326-6066.CIR-17-0661. [Epub ahead of print]

PMID:
29792298
2.

Anti-CTLA-4 therapy requires an Fc domain for efficacy.

Ingram JR, Blomberg OS, Rashidian M, Ali L, Garforth S, Fedorov E, Fedorov AA, Bonanno JB, Le Gall C, Crowley S, Espinosa C, Biary T, Keliher EJ, Weissleder R, Almo SC, Dougan SK, Ploegh HL, Dougan M.

Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):3912-3917. doi: 10.1073/pnas.1801524115. Epub 2018 Mar 26.

3.

Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1-Specific VHHs.

Dougan M, Ingram JR, Jeong HJ, Mosaheb MM, Bruck PT, Ali L, Pishesha N, Blomberg O, Tyler PM, Servos MM, Rashidian M, Nguyen QD, von Andrian UH, Ploegh HL, Dougan SK.

Cancer Immunol Res. 2018 Apr;6(4):389-401. doi: 10.1158/2326-6066.CIR-17-0495. Epub 2018 Feb 19.

PMID:
29459478
4.

PD-L1 is an activation-independent marker of brown adipocytes.

Ingram JR, Dougan M, Rashidian M, Knoll M, Keliher EJ, Garrett S, Garforth S, Blomberg OS, Espinosa C, Bhan A, Almo SC, Weissleder R, Lodish H, Dougan SK, Ploegh HL.

Nat Commun. 2017 Sep 21;8(1):647. doi: 10.1038/s41467-017-00799-8.

5.

Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.

Rashidian M, Ingram JR, Dougan M, Dongre A, Whang KA, LeGall C, Cragnolini JJ, Bierie B, Gostissa M, Gorman J, Grotenbreg GM, Bhan A, Weinberg RA, Ploegh HL.

J Exp Med. 2017 Aug 7;214(8):2243-2255. doi: 10.1084/jem.20161950. Epub 2017 Jun 30.

6.

Effect of attitudes towards patients on sexual history taking: a survey of Iranian-American physicians in California, USA.

Rashidian M, Minichiello V, Knutsen SF, Ghamsary M.

Sex Health. 2017 Nov;14(6):514-522. doi: 10.1071/SH17016.

PMID:
28618248
7.

Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas.

Dongre A, Rashidian M, Reinhardt F, Bagnato A, Keckesova Z, Ploegh HL, Weinberg RA.

Cancer Res. 2017 Aug 1;77(15):3982-3989. doi: 10.1158/0008-5472.CAN-16-3292. Epub 2017 Apr 20.

8.

Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.

Van Elssen CHMJ, Rashidian M, Vrbanac V, Wucherpfennig KW, Habre ZE, Sticht J, Freund C, Jacobsen JT, Cragnolini J, Ingram J, Plaisier L, Spierings E, Tager AM, Ploegh HL.

J Nucl Med. 2017 Jun;58(6):1003-1008. doi: 10.2967/jnumed.116.186007. Epub 2017 Feb 16.

9.

Barriers to sexual health care: a survey of Iranian-American physicians in California, USA.

Rashidian M, Minichiello V, Knutsen SF, Ghamsary M.

BMC Health Serv Res. 2016 Jul 15;16:263. doi: 10.1186/s12913-016-1481-8.

10.

The use of 18F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.

Rashidian M, Keliher E, Dougan M, Juras PK, Cavallari M, Wojtkiewicz GR, Jacobsen J, Edens JG, Tas JM, Victora G, Weissleder R, Ploegh H.

ACS Cent Sci. 2015 Jun 24;1(3):142-147. Epub 2015 Jun 3.

11.

Enzyme-Mediated Modification of Single-Domain Antibodies for Imaging Modalities with Different Characteristics.

Rashidian M, Wang L, Edens JG, Jacobsen JT, Hossain I, Wang Q, Victora GD, Vasdev N, Ploegh H, Liang SH.

Angew Chem Int Ed Engl. 2016 Jan 11;55(2):528-533. doi: 10.1002/anie.201507596. Epub 2015 Dec 2.

12.

Simultaneous Site-Specific Dual Protein Labeling Using Protein Prenyltransferases.

Zhang Y, Blanden MJ, Sudheer Ch, Gangopadhyay SA, Rashidian M, Hougland JL, Distefano MD.

Bioconjug Chem. 2015 Dec 16;26(12):2542-53. doi: 10.1021/acs.bioconjchem.5b00553. Epub 2015 Dec 4.

13.

Noninvasive imaging of immune responses.

Rashidian M, Keliher EJ, Bilate AM, Duarte JN, Wojtkiewicz GR, Jacobsen JT, Cragnolini J, Swee LK, Victora GD, Weissleder R, Ploegh HL.

Proc Natl Acad Sci U S A. 2015 May 12;112(19):6146-51. doi: 10.1073/pnas.1502609112. Epub 2015 Apr 20.

14.

Application of meta- and para-Phenylenediamine as Enhanced Oxime Ligation Catalysts for Protein Labeling, PEGylation, Immobilization, and Release.

Mahmoodi MM, Rashidian M, Zhang Y, Distefano MD.

Curr Protoc Protein Sci. 2015 Feb 2;79:15.4.1-28. doi: 10.1002/0471140864.ps1504s79.

15.

Simultaneous dual protein labeling using a triorthogonal reagent.

Rashidian M, Kumarapperuma SC, Gabrielse K, Fegan A, Wagner CR, Distefano MD.

J Am Chem Soc. 2013 Nov 6;135(44):16388-96. doi: 10.1021/ja403813b. Epub 2013 Oct 17.

16.

Chemoenzymatic site-specific reversible immobilization and labeling of proteins from crude cellular extract without prior purification using oxime and hydrazine ligation.

Mahmoodi MM, Rashidian M, Dozier JK, Distefano MD.

Curr Protoc Chem Biol. 2013;5(2):89-109. doi: 10.1002/9780470559277.ch120247.

17.

Enzymatic labeling of proteins: techniques and approaches.

Rashidian M, Dozier JK, Distefano MD.

Bioconjug Chem. 2013 Aug 21;24(8):1277-94. Review.

18.

'My culture haunts me no matter where I go': Iranian-American women discussing sexual and acculturation experiences.

Rashidian M, Hussain R, Minichiello V.

Cult Health Sex. 2013;15(7):866-77. doi: 10.1080/13691058.2013.789128. Epub 2013 May 10.

PMID:
23659387
19.

A highly efficient catalyst for oxime ligation and hydrazone-oxime exchange suitable for bioconjugation.

Rashidian M, Mahmoodi MM, Shah R, Dozier JK, Wagner CR, Distefano MD.

Bioconjug Chem. 2013 Mar 20;24(3):333-42. doi: 10.1021/bc3004167. Epub 2013 Mar 6.

20.

Chemoenzymatic reversible immobilization and labeling of proteins without prior purification.

Rashidian M, Song JM, Pricer RE, Distefano MD.

J Am Chem Soc. 2012 May 23;134(20):8455-67. doi: 10.1021/ja211308s. Epub 2012 May 8.

21.

Evaluation of alkyne-modified isoprenoids as chemical reporters of protein prenylation.

DeGraw AJ, Palsuledesai C, Ochocki JD, Dozier JK, Lenevich S, Rashidian M, Distefano MD.

Chem Biol Drug Des. 2010 Dec;76(6):460-71. doi: 10.1111/j.1747-0285.2010.01037.x. Epub 2010 Oct 11.

22.

Selective labeling of polypeptides using protein farnesyltransferase via rapid oxime ligation.

Rashidian M, Dozier JK, Lenevich S, Distefano MD.

Chem Commun (Camb). 2010 Dec 21;46(47):8998-9000. doi: 10.1039/c0cc03305g. Epub 2010 Oct 22.

23.

Comparison of thermochemistry of aspartame (artificial sweetener) and glucose.

Rashidian M, Fattahi A.

Carbohydr Res. 2009 Jan 5;344(1):127-33. doi: 10.1016/j.carres.2008.09.020. Epub 2008 Sep 26.

PMID:
18992876
24.

Adenosine deaminase and purine nucleoside phosphorylase activity in spleen cells of aged mice.

Scholar EM, Rashidian M, Heidrick ML.

Mech Ageing Dev. 1980 Apr;12(4):323-9.

PMID:
6771472

Supplemental Content

Loading ...
Support Center